1-ethyl-2-benzimidazolinone has been researched along with Injury, Myocardial Reperfusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, GW; Huang, JH; Man, YB; Yang, Q; Yao, XQ | 1 |
1 other study(ies) available for 1-ethyl-2-benzimidazolinone and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Use of intermediate/small conductance calcium-activated potassium-channel activator for endothelial protection.
Topics: Animals; Benzimidazoles; Biological Factors; Cell Hypoxia; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endothelial Cells; Female; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Myocardial Reperfusion Injury; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Small-Conductance Calcium-Activated Potassium Channels; Swine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2011 |